What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE

Completed

• Conditions: Oocyte Donation; Pregnancy

• Registration Number: NCT03668184
• Lead Sponsor: Rennes University Hospital

Brief Summary

The main goal is to determine which risk factors develop preeclampsia in this specific group of oocyte recipients.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-02
• Primary Completion: 2018-04-27
• Study Completion: 2018-04-27
• Study First Submitted: 2018-09-06
• Study First Submitted QC: 2018-09-11
• Study First Posted: 2018-09-12
• Status Verified: 2023-04
• Last Update Submitted: 2023-04-11
• Last Update Posted: 2023-04-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

• All major patients with a pregnancy of more than 22 weeks of amenorrhea resulting from an oocyte donation in one of the study centers, having given birth between January 2010 and April 2017 and not opposed to participation in the study.

Exclusion Criteria

• all pregnancies resulting from an oocyte donation abroad, persons of legal age subject to legal protection (safeguard of justice, guardianship, tutorship) and persons deprived of their liberty.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
occurrence of pre-eclampsia	through study completion, an average of 1 year

Trial Locations

Locations (2)

Clinique de la sagesse; 🇫🇷 Rennes, France

CHU de Rennes; 🇫🇷 Rennes, France